India company and founder diligence
Delivered against the family's written mandate and the evidence available for the specific opportunity.
For US family offices, endowments and private investors evaluating India, VIV acts as an independent India-side diligence, monitoring and portfolio-value partner — from manager and company verification through follow-on decisions, strategic access and exit preparation.
Find where capital can be protected, improved or realized.
The family is the client; VIV is not paid by a startup to sell the deal.
Verify what is owned, what changed and what evidence supports the investment case.
VIV is not simply a source of Indian deals. The model connects a United States family's investment mandate and operating capabilities with independently verified Indian companies — and can help portfolio companies access relevant customers, suppliers, distribution, expertise or strategic buyers when both sides consent.
The exact work depends on the family's existing exposure, direct-investment appetite, sector knowledge, team depth and India objectives.
Delivered against the family's written mandate and the evidence available for the specific opportunity.
Delivered against the family's written mandate and the evidence available for the specific opportunity.
Delivered against the family's written mandate and the evidence available for the specific opportunity.
Delivered against the family's written mandate and the evidence available for the specific opportunity.
Delivered against the family's written mandate and the evidence available for the specific opportunity.
Delivered against the family's written mandate and the evidence available for the specific opportunity.
These are positioning themes for discussion, not claims that every family in United States follows the same mandate.
VIV first captures the family's actual mandate and capabilities before sourcing or introducing opportunities.
No public deal marketplace. No mass introductions. The process begins privately with what the family wants to own, avoid, verify or solve.
Ticket, sectors, stage, geography, return/risk expectations, direct vs fund exposure, strategic capabilities and exclusions.
Identify relevant opportunities or existing exposures, then verify management, financial, customer, market and ownership evidence.
Show what supports the case, what contradicts it, what remains unknown and what conditions should precede a cheque or follow-on.
Monitor changes, activate useful cross-border capabilities, review follow-ons and prepare liquidity or strategic-exit pathways.
Verified corridor facts are separated from VIV's proposed service thesis. Sector priorities remain hypotheses until the family's mandate is known.
US–India goods and services trade was estimated at $239.6B in 2025.
Official source ↗Customers, distribution, technology, manufacturing, expertise, strategic relationships or patient capital.
VIV tests investment quality and strategic synergy separately. One does not excuse weakness in the other.
A US family office wants $5–15M India technology exposure. VIV defines the mandate, verifies shortlisted companies locally, challenges valuation and terms, and remains the India-side monitoring layer.
Service scenario; not a client case, investment offer or performance claim.
Tell us enough to understand the problem. We use the information to route the conversation to the relevant VIV service; it is not a public deal submission.
VIV treats corridor access as an investment-and-execution problem, not a list of introductions. The work separates commercial underwriting from regulated legal, tax, valuation and securities work.
Cross-border investments can involve U.S. securities rules, investor-accreditation/private-placement requirements, tax structuring, CFIUS sensitivity in certain sectors and India FEMA/ODI/FDI considerations. VIV scopes the commercial decision and routes regulated legal, tax and securities work to qualified advisers.
Return underwriting should separate operating growth, valuation change, dilution, FX and tax leakage. U.S. growth assets can support large outcomes but entry-price discipline and follow-on reserves materially affect realized returns.
Likely routes include strategic M&A, sponsor/secondary transactions, later financing liquidity and public-market exits where scale permits. Transfer rights, preference stacks and buyer universe are tested before assuming liquidity.
Key risks include high entry valuations, long private holding periods, litigation/regulatory exposure, customer concentration and USD/INR effects. VIV reduces them through evidence-led valuation, references, downside cases, rights review, milestone monitoring and early buyer mapping.
Country dynamics are a VIV commercial diligence framework, not legal, tax or regulated investment advice. Current transaction-specific requirements must be confirmed by appropriately qualified advisers before execution.
Family, strategic and institutional appetite is retained by stage, sector, ticket, return profile and India relevance, including reasons for passes.
Customers, operators, sector experts, strategic buyers and capital relationships are mapped by concrete capability and permission.
Customer references, valuation objections, governance questions, buyer logic and transaction outcomes improve later US–India decisions.